Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Benjamin Kroger"'
Autor:
Shengqing Stan Gu, Xiaoqing Wang, Xihao Hu, Peng Jiang, Ziyi Li, Nicole Traugh, Xia Bu, Qin Tang, Chenfei Wang, Zexian Zeng, Jingxin Fu, Cliff Meyer, Yi Zhang, Paloma Cejas, Klothilda Lim, Jin Wang, Wubing Zhang, Collin Tokheim, Avinash Das Sahu, Xiaofang Xing, Benjamin Kroger, Zhangyi Ouyang, Henry Long, Gordon J. Freeman, Myles Brown, X. Shirley Liu
Publikováno v:
Genome Biology, Vol 21, Iss 1, Pp 1-28 (2020)
Abstract Background Immune checkpoint blockade (ICB) therapy has improved patient survival in a variety of cancers, but only a minority of cancer patients respond. Multiple studies have sought to identify general biomarkers of ICB response, but eluci
Externí odkaz:
https://doaj.org/article/b3244746e20a48e2bb9e322dbec655a3
Autor:
Peng Jiang, Xia Bu, Michael Manos, Ana Lako, Scott Rodig, Yingtian Xie, Shengqing Gu, Henry Long, Paloma Cejas, Gordon Freeman, Wubing Zhang, Xiaoqing Wang, Nicole Traugh, Ziyi Li, Clifford Meyer, Blair Stewig, Alba Font-Tello, Klothilda Lim, Jake Conway, Alok Tewari, Zexian Zeng, Avinash Das Sahu, Collin Tokheim, Jason Weirather, Jingxin Fu, Benjamin Kroger, Jin Hua Liang, Benjamin Gewurz, F. Stephen Hodi, Myles Brown, X Shirley Liu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/bab53d3c27fa4f8ba5c795696a9cf58b
Autor:
X. Shirley Liu, Myles Brown, F. Stephen Hodi, Benjamin E. Gewurz, Henry W. Long, Scott Rodig, Gordon J. Freeman, Paloma Cejas, Jin Hua Liang, Benjamin Kroger, Yi Zhang, Jingxin Fu, Jason L. Weirather, Collin Tokheim, Avinash Das Sahu, Zexian Zeng, Alok K. Tewari, Jake Conway, Klothilda Lim, Ana Lako, Evisa Gjini, Alba Font-Tello, Michael P. Manos, Xia Bu, Yingtian Xie, Blair Stewig, Clifford Meyer, Ziyi Li, Nicole Traugh, Peng Jiang, Xiaoqing Wang, Wubing Zhang, Shengqing Stan Gu
RNA-seq and ATAC-seq of TRAF3-normal and -deficient B16F10 cells treated with vehicle control or IFNγ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a3314a396aff5c586317beda35765e
https://doi.org/10.1158/2159-8290.22540307
https://doi.org/10.1158/2159-8290.22540307
Autor:
X. Shirley Liu, Myles Brown, F. Stephen Hodi, Benjamin E. Gewurz, Henry W. Long, Scott Rodig, Gordon J. Freeman, Paloma Cejas, Jin Hua Liang, Benjamin Kroger, Yi Zhang, Jingxin Fu, Jason L. Weirather, Collin Tokheim, Avinash Das Sahu, Zexian Zeng, Alok K. Tewari, Jake Conway, Klothilda Lim, Ana Lako, Evisa Gjini, Alba Font-Tello, Michael P. Manos, Xia Bu, Yingtian Xie, Blair Stewig, Clifford Meyer, Ziyi Li, Nicole Traugh, Peng Jiang, Xiaoqing Wang, Wubing Zhang, Shengqing Stan Gu
Immune checkpoint blockade (ICB) therapy revolutionized cancer treatment, but many patients with impaired MHC-I expression remain refractory. Here, we combined FACS-based genome-wide CRISPR screens with a data-mining approach to identify drugs that c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::339909281206a9e55e90319937e3c2d6
https://doi.org/10.1158/2159-8290.c.6549347.v1
https://doi.org/10.1158/2159-8290.c.6549347.v1
Autor:
X. Shirley Liu, Myles Brown, F. Stephen Hodi, Benjamin E. Gewurz, Henry W. Long, Scott Rodig, Gordon J. Freeman, Paloma Cejas, Jin Hua Liang, Benjamin Kroger, Yi Zhang, Jingxin Fu, Jason L. Weirather, Collin Tokheim, Avinash Das Sahu, Zexian Zeng, Alok K. Tewari, Jake Conway, Klothilda Lim, Ana Lako, Evisa Gjini, Alba Font-Tello, Michael P. Manos, Xia Bu, Yingtian Xie, Blair Stewig, Clifford Meyer, Ziyi Li, Nicole Traugh, Peng Jiang, Xiaoqing Wang, Wubing Zhang, Shengqing Stan Gu
Supplementary Figures S1-S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe7fd5557022c9cb76403aa86997bdd
https://doi.org/10.1158/2159-8290.22540316
https://doi.org/10.1158/2159-8290.22540316
Autor:
Benjamin Kroger, Yi Huang, Prapti Patel, Aimaz Afrough, Gurbakhash Kaur, Larry D. Anderson, Farrukh T. Awan, Praveen Ramakrishnan, Kunal Verma, Russell Vittrup, Robert H. Collins, Madhuri Vusirikala, Yazan F. Madanat, Roni Tamari, Stephen S. Chung
Publikováno v:
Blood. 140:9833-9835
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1435a70ca2874055c3b0f083ac0bc79
https://doi.org/10.1182/blood-2022-171179
https://doi.org/10.1182/blood-2022-171179
Autor:
Benjamin Kroger, Yi Huang, Prapti Patel, Aimaz Afrough, Gurbakhash Kaur, Larry Anderson, Farrukh Awan, Praveen Ramakrishnan, Kunal Verma, Russell Vittrup, Robert H Collins, Madhuri Vusirikala, Yazan F Madanat, David Sallman, Carmelo Gurnari, Jaroslaw Maciejewski, Roni Tamari, Stephen Chung
Publikováno v:
Blood Cancer Discovery. 4:A23-A23
Malignant hematopoietic stem cells (HSCs) initiate the myelodysplastic syndromes (MDS) and drive treatment failure through their resistance to all non-transplant therapies. As a result, allogeneic stem cell transplantation (allo-SCT) is the only cura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb18e8558e16875da2179bf1b5dedc05
https://doi.org/10.1158/2643-3249.aml23-a23
https://doi.org/10.1158/2643-3249.aml23-a23
Autor:
Vianey Quaney, Benjamin Kroger, Aishwarya Sannareddy, Umar Khan, Fatma Kalkan, Robert H. Collins, Yazan F. Madanat, Madhuri Vusirikala, Yi Huang, Farrukh T. Awan, Praveen Ramakrishnan, Aimaz Afrough, Larry D. Anderson, Stephen S. Chung, Gurbakhash Kaur
Publikováno v:
Cancer Research. 83:5925-5925
INTRODUCTION: Clonal hematopoiesis of indeterminate potential (CHIP) is defined by the expansion of progeny derived from hematopoietic stem cells that have acquired somatic mutations at a VAF greater than 2%. CHIP manifests in 10% of patients older t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::583ac7a9e6b0ce4a4c05c8994feae954
https://doi.org/10.1158/1538-7445.am2023-5925
https://doi.org/10.1158/1538-7445.am2023-5925
Autor:
Henry W. Long, Blair Stewig, Alba Font-Tello, Xiaoqing Wang, Michael Manos, Ziyi Li, X. Shirley Liu, Jingxin Fu, Paloma Cejas, Gordon J. Freeman, Alok K. Tewari, Scott J. Rodig, Yi Zhang, Zexian Zeng, F. Stephen Hodi, Clifford A. Meyer, Yingtian Xie, Xia Bu, Wubing Zhang, Collin Tokheim, Avinash Das Sahu, Jason L. Weirather, Jake Conway, Klothilda Lim, Myles Brown, Jin Hua Liang, Evisa Gjini, Shengqing Stan Gu, Ana Lako, Peng Jiang, Benjamin Kroger, Nicole Traugh, Benjamin E. Gewurz
Publikováno v:
Cancer Discov
Immune checkpoint blockade (ICB) therapy revolutionized cancer treatment, but many patients with impaired MHC-I expression remain refractory. Here, we combined FACS-based genome-wide CRISPR screens with a data-mining approach to identify drugs that c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a042e6d12146ecc33cf2f861350464
https://doi.org/10.1158/2159-8290.cd-20-0812
https://doi.org/10.1158/2159-8290.cd-20-0812
Autor:
Toby Thomas, Yuanyuan Ji, Fatma Kalkan, Albert Son, Ambarish Pandey, Vinayak Subramanian, Naveen Premnath, Michalis Agathocleous, Qing Ding, Alexander G. Bick, Benjamin Kroger, Dan Tong, Stephen S. Chung
Publikováno v:
Blood. 140:8611-8612
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::562a3e6d6166c125d68f4a6119cdae4e
https://doi.org/10.1182/blood-2022-171138
https://doi.org/10.1182/blood-2022-171138